<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="210272">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00350129</url>
  </required_header>
  <id_info>
    <org_study_id>005-ZAC-2004-002</org_study_id>
    <nct_id>NCT00350129</nct_id>
  </id_info>
  <brief_title>Effect of Glucose on Ocular Blood Flow</brief_title>
  <official_title>Influence of Plasma Glucose Levels on Retinal Vascular Diameter and Choroidal Blood Flow in Vasospastic Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to assess the effect of glucose on retinal vascular diameter in
      otherwise healthy vasospastic subjects compared to non-vasospastic controls.

      The secondary objective is to compare the effect of glucose also on choroidal blood flow in
      otherwise healthy vasospastic subjects with non-vasospastic controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is known that a glucose load can induce an increase in ocular blood flow. Acute
      hyperglycemia increases retinal vessel diameters in animals and humans. The purpose of this
      study is to compare the effect of glucose on the ocular blood flow in vasospastics and
      nonvasospastics. Body core temperature depends on basal metabolism. Peripheral
      vasoconstriction is a physiological way to preserve core temperature of the body. The
      etiology of primary vasospastic syndrome is unknown and potentially represents simply a
      reaction to a defective metabolism. Based on this hypothesis, vasospastics are expected to
      show a different vascular reaction to glucose.

      On both study days, after an overnight fast, the subjects will be seated for 30 minutes in
      the Lab and local tropicamide will be applied for pupil dilatation. After stabilisation of
      blood pressure Retinal vessel diameter and choroidal blood flow will be assessed. Baseline
      blood glucose levels will be measured. Afterwards study substance (75 gram of Glucose or
      Aspartate) will be applied in 3 dl of water. One and a half hour later, the vascular
      measurements will be repeated. Ath the end of hemodynamic assessments, blood sugar level
      will be measured again.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <completion_date type="Actual">February 2003</completion_date>
  <primary_completion_date type="Actual">February 2003</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Coronary Vasospasm</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>healthy vasospastic subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>healthy non-vasospastic subjects</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        healthy vasospastic subjects, healthy non-vasospastic subjects
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No history of the following problems: ocular or systemic disease; chronic or current
             systemic or topical medication; or of drug or alcohol abuse

          -  normal blood pressure (100-140 / 60-90 mmhg)

          -  best corrected visual acuity above 20/25 in both eyes

          -  no pathological findings upon a slit-lamp examination and indirect fundoscopy

          -  ametropia within -3 to +3 diopters of spherical equivalent

          -  less than 1 diopter astigmatism

          -  IOP &lt; 20 mmHg in both eyes

          -  Subjects will be classified as vasospastic if they relate a clear history of frequent
             cold hands (answering yes to the questions: &quot;do you have always cold hands, even
             during summer time?&quot; and &quot;do other people tell you that you have cold hands?&quot;) and as
             normals if they deny such a history

          -  Vasospastic propensity will also be assessed by capillaroscopy

        Exclusion Criteria:

          -  Subjects describing &quot;sometimes cold hands&quot;

          -  if the test substance cannot be ingested

          -  not obtainable ocular blood flow measurements

          -  abnormally high levels of glucose at any point in time
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Selim Org√ºl, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Basel, Eye Clinic</name>
      <address>
        <city>Basel</city>
        <state>BS</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <lastchanged_date>September 25, 2008</lastchanged_date>
  <firstreceived_date>July 7, 2006</firstreceived_date>
  <responsible_party>
    <name_title>Selim Orgul</name_title>
    <organization>University Hospital, Basel, Switzerland</organization>
  </responsible_party>
  <keyword>glucose</keyword>
  <keyword>vasospasm</keyword>
  <keyword>RVA</keyword>
  <keyword>LDF</keyword>
  <keyword>vasospastic subjects</keyword>
  <keyword>non-vasospastic subjects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Vasospasm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
